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Abstract
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Motion mitigation strategies are needed to fully realize the theoretical advantages of scanned ion
beam therapy for patients with moving tumors. The purpose of this study was to determine
whether a new four-dimensional (4D) optimization approach for scanned-ion-beam tracking could
reduce dose to avoidance volumes near a moving target while maintaining target dose coverage,
compared to an existing 3D-optimized beam tracking approach. We tested these approaches
computationally using a simple 4D geometrical phantom and a complex anatomic phantom, that
is, a 4D computed tomogram of the thorax of a lung cancer patient. We also validated our findings
using measurements of carbon-ion beams with a motorized film phantom. Relative to 3Doptimized beam tracking, 4D-optimized beam tracking reduced the maximum predicted dose to
avoidance volumes by 53% in the simple phantom and by 13% in the thorax phantom. 4Doptimized beam tracking provided similar target dose homogeneity in the simple phantom
(standard deviation of target dose was 0.4% versus 0.3%) and dramatically superior homogeneity
in the thorax phantom (D5-D95 was 1.9% versus 38.7%). Measurements demonstrated that
delivery of 4D-optimized beam tracking was technically feasible and confirmed a 42% decrease in
maximum film exposure in the avoidance region compared with 3D-optimized beam tracking. In
conclusion, we found that 4D-optimized beam tracking can reduce the maximum dose to
avoidance volumes near a moving target while maintaining target dose coverage, compared with
3D-optimized beam tracking.
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1. Introduction
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Ion beam therapy can reduce dose to healthy tissues near a cancer target and thus decrease
the potential for severe side effects of radiation therapy, while maintaining tumor control,
compared with x-ray and electron therapies, due to the physical energy loss characteristics
of ions such as protons or carbon ions stopping in matter. In some cases, the additional
degrees of freedom realized when using actively scanned ion beams instead of passively
scattered ion beams can further improve normal tissue sparing. Actively scanned ion beam
therapy typically uses fields composed of thousands of ion pencil beams, that is, narrow
(few mm width) ion beams that are each approximately monoenergetic and monodirectional,
to cover the lateral and longitudinal extent of a target volume. This approach can provide a
high conformality and uniformity of target dose but requires a highly precise delivery
system and accurate knowledge of the patient anatomy at the time of irradiation.
Furthermore, heavier ions, such as carbon-12, exhibit increased relative biological
effectiveness (RBE) for tumor control and cell killing near the Bragg peak, which may be
advantageous either for treating radioresistant tumors or for exploiting the comparably low
RBE found in the ion beam entrance channel to spare normal tissues upstream of the tumor
(Schardt et al., 2010; Elsässer et al., 2010). To date, only a few approaches have been
developed that could utilize this theoretically promising therapy for patients with moving
thoracic tumors, such as lung cancer patients.
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In order to treat patients with moving thoracic tumors using scanned ion beams, motion
mitigation strategies are needed to ensure uniform dose coverage of the moving target and to
best minimize dose to normal tissues near the moving target (Bert and Durante, 2011). Beam
tracking is one of the more technically challenging motion mitigation strategies to
implement for scanned ion beams but potentially provides a highly conformal dose to targets
undergoing periodic motion. In this approach, individual ion pencil beams are magnetically
steered throughout the patient respiratory cycle such that each individual ion-beam Braggpeak position remains in the same local subvolume of the target during the entire respiratory
cycle (Grözinger et al., 2004). The beam tracking system implemented at the GSI
Helmholtzzentrum für Schwerionenforschung GmbH (GSI) in Darmstadt, Germany uses
magnetic deflection to track lateral target motion and a fast (i.e., within a few ms) energydegrading wedge system to compensate for anatomical changes in radiological depth of the
target (Saito et al., 2009). Prior to treatment delivery, beam tracking offsets are calculated
using both a four-dimensional computed tomogram (4DCT) and deformable image
registration vectors, which register anatomic motion through the discrete temporal states of
respiration represented by the 4DCT (Bert and Rietzel, 2007). By applying these lateral and
longitudinal tracking offsets, ion pencil beams can be delivered in any phase of respiration
since the ion beams track the tumor for the entire respiratory cycle. In addition, dosimetric
target margins for scanned ion beam tracking theoretically remain as sharp and conformal as
those possible for stationary anatomy. The previously-proposed, 3D-optimized-beam-
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tracking approach of Bert and Rietzel (2007) achieved adequate target dose coverage for
some patients but did not provide a general solution for patients with tumors that deform or
rotate significantly during respiration. To elucidate, in their approach, particle numbers were
optimized using a single 3D reference phase of the 4DCT, e.g., end-exhale. Consequently,
4D dose was deteriorated somewhat, even with perfect geometric tracking of target motion,
since off-axis dose contributions from each ion beam can distort in the presence of complex
tissue motion (van de Water et al., 2009). To address this problem, Lüchtenborg et al.
(2011) proposed a real-time 4D dose compensation method for scanned ion beam tracking
that improves target dose coverage by adapting particle numbers in real-time based on the
motion status of the target during the delivery of each ion beam. Recently, Graeff et al. (in
press) devised another new strategy for treating a moving target, which irradiated different
sections of the target volume in predetermined motion phases and used 4D optimization to
achieve uniform target dose coverage. Importantly, none of these proposed beam-tracking
approaches have been applied to patient treatment, and, more generally, the ideal method to
apply scanned ion beam therapy to patients with moving tumors, if one even exists, is not
yet known. Based on the approach of Lüchtenborg et al. (2011), we were inspired to
investigate 4D optimization as a strategy to further improve target dose coverage and
potentially control dose to healthy tissue for scanned ion beam tracking, which their study
did not address. Whereas many motion mitigation strategies attempt to eliminate or reduce
the impact of time and motion as factors in therapy, we sought to exploit time and motion as
potential advantages in therapy using 4D optimization.
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Several studies have reported 4D-optimization strategies for photon therapy. Zhang et al.
(2004) incorporated respiratory motion data into optimization of photon tomotherapy plans
and demonstrated improved target dose conformity. Trofimov et al. (2005) developed four
new approaches to optimize intensity-modulated photon fields for lung and liver patients
with moving tumors. Nohadani et al. (2010) reported another 4D optimization approach for
photon therapy that improved dose coverage compared to beam gating for lung cancer
patients and reduced dose to healthy lung and was also more robust to irregular breathing
than beam gating. Chin and Otto (2011) further demonstrated in phantom studies that 4D
optimization can be applied to volumetric modulated arc therapy to spare avoidance
volumes near a moving target. These studies suggest that the added degree of freedom,
namely time, facilitates the optimization process and yields improved target dose coverage
and to spare avoidance volumes near a moving target. However, to our knowledge, 4D
optimization for ion beam therapy has only been recently reported (Graeff et al., in press),
and the strategy that we propose here has not been previously reported in the literature.
The purpose of our study was to propose a new beam tracking approach using 4D
optimization for scanned ion therapy of moving tumors. We tested the working hypothesis
that 4D-optimized scanned ion beam tracking can reduce dose to avoidance volumes outside
a moving target compared with 3D-optimized scanned carbon beam tracking while
maintaining adequate target dose coverage. We also sought to demonstrate that delivery of
4D-optimized scanned ion beam tracking is technically feasible. To achieve these goals, we
simulated our proposed approach using a research treatment planning system for both a
simple 4D geometrical phantom and for a complex anatomic phantom using a thoracic
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4DCT of a lung cancer patient. Furthermore, we irradiated moving films using 3D- and 4Doptimized scanned carbon-ion beam tracking to experimentally validate our simulation
studies.

2. Methods
2.1. 4D Optimization
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In this work, we propose a 4D-optimization approach for scanned ion beam tracking
therapy. Our approach involves planning of a 4D field composed of ion pencil beams, each
with a unique geometric position, energy, and particle number (i.e., number of particles
incident on the patient in that pencil beam), determined for individual motion states. Figure
1 compares the proposed approach for 4D-optimized scanned ion beam tracking with a
previously proposed approach using 3D-optimized scanned ion beam tracking. In essence,
our approach seeks to reduce dose to avoidance volumes near the moving target while
preserving adequate target coverage. This was accomplished by optimizing the particle
numbers for each pencil beam for each motion state. We implemented our approach in the
TRiP4D research treatment planning system (TPS) code for scanned ion therapy (Krämer et
al., 2000; Richter et al., 2013) using the C programming language. The TPS already had the
capability to calculate 4D dose distributions and plan beam-tracking offsets. The
implementation of our proposed approach required modifications and extensions to the
optimization routines to incorporate 4DCT data, deformable image registration vectors, and
beam tracking offsets that were necessary to enable optimization of a 4D field. It should be
noted that, for the purposes of this study, we optimized absorbed dose; further TPS
development will be needed to allow 4D-optimization of RBE-weighted dose.
Our treatment planning workflow for 4D-optimized scanned ion beam tracking included the
sequence of steps below. The sequence was used for planning treatments of the simple
phantom and the thorax.

NIH-PA Author Manuscript

1.

A 3D scanned ion field was planned to cover a 3D representation of the 4D target
volume in a reference motion state, with Bragg peaks for each pencil beam evenly
spaced throughout the target volume. This step required a 3D reference-state image
extracted from a 4DCT that represented the patient anatomy in the reference state
and target contours to determine the necessary energies and lateral coordinates of
ion pencil beams.

2.

Particle numbers were optimized for the 3D scanned ion field to provide uniform
dose throughout the target for the reference motion state.

3.

To plan beam tracking, 4DCTs and corresponding deformable image registration
vectors were used to calculate lateral and longitudinal beam-tracking offsets for
each pencil beam for each motion state, so that each pencil beam would track
changes in target position and radiological depth during treatment. Thus, the
treatment plan at this stage was composed of a 3D field and a 4D look-up table of
tracking offsets (Bert and Rietzel, 2007).

4.

As the starting condition for the 4D field, the 3D field, created in Steps 1 and 2,
was copied for each of M motion states, corresponding to states of the 4DCT, to
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produce a 4D field. Tracking offsets for each pencil beam for each motion state
were included in the 4D field description. Initially, particle numbers N for each
pencil beam in all motion states of the 4D field were identical to those in the 3D
field, though scaled uniformly by 1/M.
5.

For 4D optimization of the particle numbers N in the 4D fields, a dose correlation
matrix A was calculated that contained the dose contribution, per incident particle
number (nijk), for each ion pencil beam (i) in each motion state (j) for each field (k)
to each voxel (p) in the target and avoidance volumes. To calculate the dose
correlation matrix elements (aijkp) of A, 4D pencil beam dose calculations were
performed similarly to 3D pencil beam dose calculations except that (1) individual
voxel coordinates, defined in a reference motion state, for the target and avoidance
volumes were transformed for non-reference motion states using deformable image
registration vectors, (2) individual ion pencil beams were offset by their tracking
offsets that were determined in Step 3, and (3) the appropriate 3DCT state from the
4DCT was used in dose calculation. The resulting dose correlation matrix was used
to calculate 4D dose (D) to the pth (moving) voxel by

NIH-PA Author Manuscript

(1)

where Ljk is the number of pencil beams in an individual motion state j for a given
field k. B is the number of fields used, for example, with different gantry angle or
couch angle. In this study, we only used single fields (B = 1), but our TPS
implementation enables multi-field intensity-modulated optimization.
6.

An objective function χ2(N) was defined to express differences between the
prescribed and actual dose to the target (T) and to penalize dose to avoidance
volumes (V) above a given threshold dose for each avoidance volume (Horcicka et
al., 2013).

(2)
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where DRx was the prescribed target dose and the terms wT and wV were adjustable
parameters to weight the objective function to preferentially greater emphasize
either prescribed target dose coverage or avoidance volume dose exceeding a
maximum allowed value DMax, as desired. The Heaviside step function Θ served to
exclude voxels receiving a dose below a user specified maximum dose limit DMax
from adding penalty to the objective function. Specifying DMax for avoidance
volumes near the target allowed fine control over tradeoffs between the competing
objectives of uniform target dose coverage and minimal dose to avoidance
volumes.
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Conjugate gradient minimization (Fletcher and Reeves, 1964) was used to solve for
particle numbers N in the 4D scanned ion field that minimized the objective
function.

2.2. Water Phantom Study
To compare our 4D-optimized scanned ion beam-tracking approach against an existing 3Doptimized scanned ion beam-tracking approach, we designed a test case that utilized a
simple water-box phantom containing a moving spherical target and a static rectangular
solid avoidance volume. The simple phantom consisted of two rectangular-solid slabs of
water. A stationary, proximal slab contained a rectangular solid avoidance volume, upstream
of the target. A distal slab contained a 3-cm spherical target volume and oscillated along the
x-axis, perpendicular to the beam direction, with sinusoidal motion with 2-cm peak-to-peak
amplitude and a period of 4 s. We designed this phantom to allow two distant motion states
in which beams could deliver dose to portions of the target and while missing the avoidance
volume.
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For treatment planning, voxelized 4DCT data and contours were generated to represent this
phantom, and corresponding image registration vectors were created to describe the
sinusoidal motion of the phantom for 11 discrete motion states. The motion states were
equally spaced in distance between the minimal and maximal displacements of the spherical
target volume. Using the TPS, a single scanned carbon ion field was designed to irradiate the
spherical target uniformly with 1 Gy, with the beam first passing through the stationary slab
containing the avoidance volume. The positions of the Bragg peaks of individual pencil
beams were distributed throughout the target with 2 mm lateral spacing and 3 mm waterequivalent depth spacing. The beams were focused to approximately 6 mm full-width at
half-maximum (FWHM) spot size each at the center of the target. A 3-mm ripple filter was
used to broaden the width of the carbon Bragg peaks along the depth axis (Weber and Kraft,
1999).
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The 3D-optimized beam tracking plan was prepared using only steps 1-3 in the sequence
described in Section 2.1. These plans comprised a 3D field and a list of tracking offsets for
each pencil beam for each motion state. We did not restrict dose to the avoidance volume in
3D optimization for this water phantom case, since that objective directly conflicted with the
objective of uniform target dose for 3D optimization in the static reference motion state. For
3D optimization, our solution was considered to have converged and optimization was
stopped once the relative change in our objective function after each successive iteration
dropped below 10-3. The 4D-optimized scanned carbon tracking plan was prepared
according to steps 1-7 in the sequence described in Section 2.1. For 4D optimization
objectives, we included a uniform target dose of 1 Gy (wT = 1) and a maximum dose to the
avoidance volume of 0.01 Gy (wV = 0.01). To prevent the occurrence of overly high doses in
regions outside the target and avoidance volume, we also added a thin avoidance volume
layer, 2-mm depth-thickness at 2-cm depth, throughout the entire proximal slab, with a
maximum allowed dose of 1 Gy (wV = 1).
We investigated the rate of convergence of the 4D objective function as a function of the
number of iterations. Based on our initial findings, we replaced the iteration stopping criteria
Phys Med Biol. Author manuscript; available in PMC 2015 July 07.
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discussed above with a fixed number (1000) of iterations. We will return to this topic in
Section 3.1. 4D dose calculations were performed for both 3D- and 4D-optimized scanned
carbon beam tracking for the moving phantom. A 3D dose calculation was also performed
for a static reference case without motion.
In summary, our water phantom study compared calculated dose to the target and avoidance
volumes for (1) static 3D irradiation with the target fixed in the reference motion state, (2)
3D-optimized scanned carbon beam tracking, and (3) 4D-optimized scanned carbon beam
tracking. 4D dose distributions were transformed to the reference motion state for dosimetric
analysis. Dose distributions were visualized using 2D dose color wash planes and
quantitatively compared using statistics from analyses of dose-volume histograms.
2.3. Lung Cancer Patient Study
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In order to demonstrate that our 4D-optimized beam tracking approach could optimize 4D
scanned carbon fields for a complex thoracic anatomy and moving organs, we tested our
approach using a 4DCT of a lung cancer patient. The 59-year-old woman in our study was
diagnosed with stage IV, T2/N2/M1, non-small-cell lung cancer and a 4.5-cm primary tumor
in the left lower lobe near the heart. Peak-to-peak tumor motion amplitude was
approximately 2.5 cm. She previously received x-ray radiotherapy at The University of
Texas MD Anderson Cancer Center (UTMDACC) (Houston, TX). Prior to her treatment,
4DCT image data were acquired with a 16-slice CT scanner (Philips, Mx8000 IDT,
Amsterdam, The Netherlands) and binned into 10 phases of the respiratory cycle with equal
duration (Keall et al., 2004). Data for this patient were collected under a retrospective
research protocol approved by the UTMDACC Institutional Review Board. All protected
health information was removed from our copy of the electronic medical record.
In order to plan beam tracking and to perform 4D dose calculations, deformable 4D image
registration vectors were calculated from the 4DCT data using the Plastimatch software
system using B-splines (Shackleford et al., 2010). Figure 2 shows the deformable image
registration vectors overlaid on a CT slice for the reference phase at end-exhale,
qualitatively illustrating the extent of organ motion.

NIH-PA Author Manuscript

Using the TPS, we designed a single posterior-to-anterior scanned ion field to irradiate the
clinical target volume (CTV). Although a lone field would most likely not be used clinically,
we chose this to facilitate a severe test of the dosimetric performance of our algorithm at the
distal target edge near the heart. For a reference motion state at end-exhale, positions of the
carbon pencil beam Bragg peaks were planned to cover the CTV with a uniform 2-mm
lateral spacing and a focal size of 6-mm FWHM. We used a 3-mm water-equivalent spacing
between isoenergy slices and a corresponding 3 mm ripple filter. Particle numbers for each
pencil beam were initially optimized in 3D to provide 100% of the prescribed dose to the
CTV (wT = 1) and zero dose to the heart (wV = 10). 3D optimization was stopped once the
relative change in the objective function dropped below 10-3 between each iteration. Where
the CTV contours overlapped the heart volume, that volume was treated as CTV. After
planning a 3D field to irradiate the target in the reference motion state, beam tracking offsets
were computed for each pencil beam in each motion state using 4D deformable image
registration vectors and 4DCT data, as described in steps 1-3 of the sequence in Section 2.1.
Phys Med Biol. Author manuscript; available in PMC 2015 July 07.
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For 4D-optimized beam tracking, we performed steps 1-7 in Section 2.1. For 4D
optimization, we specified criteria of uniform CTV dose coverage (wT = 1) and a limit of
zero dose to the heart (wV = 10). As in the water phantom study, we investigated
convergence of the 4D objective function as a function of the number of iterations. Based on
this, we used 1000 iterations with no stopping criteria.
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We computed 4D dose distributions in the lung patient for static irradiation, 3D-optimized
beam tracking, and 4D-optimized beam tracking. All 4D dose distributions were
transformed to a 3D reference state at end-exhale for dosimetric analysis. Dose distributions
were visualized using 2D dose color wash planes and dose volume histograms. Quantitative
comparisons utilized dose-volume summary statistics. For the lung CTV, we chose the dosevolume metrics of V95 to quantify target dose coverage, V107 to quantify target overdosage,
and D5-D95 to quantify target dose homogeneity. To define these metrics, V95 was the
percentage of tumor volume receiving at least 95% of the prescribed dose, V107 was the
percentage of tumor volume receiving at least 107% of the prescribed dose, and D5-D95 was
the difference between D5, the minimum dose to the 5% of tumor volume receiving the
highest dosage, and D95, the minimum dose to the 95% of tumor volume receiving the
highest dosage. For the heart, we analyzed the mean and maximum dose values. To
investigate the sensitivity of our approach to interfractional motion changes and differences
in breathing pattern, we also simulated treatment for both 3D-optimized beam tracking and
4D-optimized beam tracking using an initial 4DCT (acquired at Week 0) for treatment
planning and a later 4DCT (acquired at Week 1) for treatment delivery. We calculated the
effects of these motion changes on dose-volume statistics for the lung CTV and the heart.
2.4. Validation Experiment
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To demonstrate the feasibility of delivering 4D-optimized beam tracking therapy and to
validate the findings of our simulation studies, we irradiated a 4D phantom with a scanned
carbon beam and measured tracking performance using radiographic films. The 4D
treatment delivery system for scanned ion beam tracking is depicted schematically in Figure
3. Similar to the water-box phantom described in Section 2.2, we designed a disk-shaped
moving target with 3-cm diameter and sinusoidal motion with 2-cm amplitude and 4-s
period perpendicular to the beam central axis. We planned a single isoenergy layer of carbon
ion pencil beams with 2-mm lateral spacing to deliver uniform dose to the moving target and
minimal dose to the static avoidance volume upstream of the target.
Experimentally, this case was represented by a radiographic film (Eastman Kodak, XOMAT V, Rochester, USA) placed, in its jacket, on a motorized table at isocenter on the
patient couch and another film placed upstream of the motorized table, which did not move.
A laser distance indicator was used to detect target motion for our 4D treatment control
system. Our 4D TCS includes a continuously running software loop that processes the
digitized signal from the laser distance indicator and determines the motion state using an
amplitude-based detection algorithm (Lüchtenborg et al., 2011). Our experimental setup is
shown in Figure 4.
We delivered our 4D scanned carbon fields to the films using a sequential gating technique.
For example, all particles prescribed for motion state 1 were delivered before any particles
Phys Med Biol. Author manuscript; available in PMC 2015 July 07.
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were delivered for motion state 2. In the case that a motion state change occurred before
irradiation was finished, the particle spill was gated by stopping the radiofrequency
knockout exciter until the motion table returned to the unfinished motion state and the spill
extraction was resumed. In this manner, we irradiated scanned carbon ion treatment plans
using both 3D-optimized beam tracking and 4D-optimized beam tracking. Films were
processed and digitally scanned using standard methods (Spielberger et al., 2003), and we
analyzed the film exposure, quantified as optical density, in both the moving target region
and the avoidance region of the films for both 3D- and 4D-optimized beam tracking.

3. Results
In general, we observed that 4D optimization performed as expected. The additional degrees
of freedom in the 4D approach (i.e., the particle numbers for each pencil beam for each
motion state) yielded dosimetric advantages, such as reduced dose to avoidance volumes and
superior uniformity in the CTV.
3.1. Water Phantom Study
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Carbon ion particle numbers N were determined for 3D- and 4D-optimized beam tracking.
Fluence maps for a single energy-slice are shown in Figure 5. As expected, particle numbers
were reduced by 4D optimization for certain motion states for pencil beams that passed
through the proximal static avoidance volume to reach the distal moving target volume. To
compensate this, particle numbers were increased using 4D optimization for those motion
states that allowed pencil beams to irradiate the target without passing through the proximal
avoidance volume.
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In 4D optimization, the evaluation of the objective function χ2(N) is shown as a function of
iteration number in Figure 6. The erratic shape of the relative change in objective function in
early iterations led us to abandon our typical criteria for terminating optimization, which
was to stop when the relative change dropped below 10-3. Instead, we estimated from these
plots that the relative change in the objective function became stable and remained below
10-3 near 1000 iterations. Thus we used 1000 iterations of 4D optimization without any
abort criteria for the rest of our study, and we visually confirmed that the objective function
did not worsen by neglecting the typical stopping criteria. To better visualize dosimetric
improvements as a function of iteration number, 4D dose distributions are plotted for
various iteration numbers in Figure 7. Due to our choice of optimization constraints, the
target dose was drastically decreased in the first iteration to spare dose to the avoidance
volume. However, after a large number of iterations the target dose coverage was restored,
even though a reduction of dose to the avoidance volume was maintained.
Figure 8 plots 2D dose color wash planes comparing 4D-optimized beam tracking against
3D-optimized beam tracking, along with a static irradiation. Dose to the avoidance volume
for 4D-optimized beam tracking was greatly reduced, mean dose decreased by 70% and
maximal dose decreased by 53%, compared to the corresponding values from the 3Doptimized plan. Dose statistics for the moving sphere and avoidance volume are presented in
Table 1 for each treatment plan. For all treatment plans, dose coverage to the moving target
was nearly identical. In the avoidance volume, dose distributions for 3D-optimized beam
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tracking and static irradiation were similar, though the dose distribution for 3D-optimized
tracking appeared generally blurred in the lateral direction. This was expected because the
carbon-ion beams were laterally tracking the moving target during irradiation.
3.2. Lung Cancer Patient Study
For the lung cancer patient simulation, we observed a decrease in the maximal dose to the
avoidance volume (i.e., the heart) using 4D-optimized beam tracking instead of 3Doptimized beam tracking. Interestingly, 4D optimization provided highly uniform CTV
coverage, similar to that for a static irradiation and superior to that for 3D-optimized beam
tracking.
Figure 9 plots the evaluation of the objective function χ2(N) shown as a function of iteration
number. Similar to the water phantom results (cf. Figure 6), we observed from these plots
that the relative change in the objective function was somewhat erratic but seemed to fall
consistently below 10-3 near 1000 iterations. Thus 1000 iterations were used for our study.
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Figure 10 plots dose planes comparing 4D-optimized tracking against 3D-optimized
tracking and static irradiation. The same data are shown in dose-volume histogram (DVH)
form in Figure 11. For the static irradiation, the target dose distribution was approximately
uniform throughout the CTV. 3D-optimized beam tracking provided a dose distribution that
remained conformal to the geometric target boundary. However, degradation of dose
uniformity was observed inside the target with regions of overdosage and underdosage. In
particular, a region of overdosage extends distally beyond the CTV into the heart. This nonideal dose coverage was likely caused by a partial failure of the 3D-optimized tracking to
compensate for dosimetric effects of rotating or deforming tissues or for changes in the
scattering properties of material upstream of the target.
Our findings regarding sensitivity to interfractional motion changes for the lung patient are
presented in Table 2. Target dose coverage (V95) decreased by 12% and 11% for 3Doptimized beam tracking and 4D-optimized beam tracking, respectively, due to changes in
organ motion between Week 0 and Week 1. At Week 1, the target dose distribution was
better for 4D-optimized beam tracking than for 3D-optimized tracking by all metrics, but
differences in dose to the heart became less evident.
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In summary, 4D-optimized beam tracking improved target dose uniformity, compared to
3D-optimized beam tracking (i.e., D5-D95 was reduced by 95%). In addition, by using 4Doptimized tracking we observed a 13% decrease in maximum dose to the heart, compared to
3D-optimized tracking (cf. Table 1). Analysis of the organ motion seen in the deformable
image registration map (see Figure 2) suggests that similar motion between the lung CTV
and the heart restricted our ability to reduce dose to the heart as greatly as that possible in
our water phantom study.
3.3. Validation Experiment
We experimentally confirmed the ability of 4D-optimized beam tracking to reduce dose to
an avoidance volume near a moving target compared with 3D-optimized beam tracking for
our moving target phantom using a scanned carbon ion beam. Figure 12 shows our film
Phys Med Biol. Author manuscript; available in PMC 2015 July 07.
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measurements from the 4D-optimized beam tracking validation experiment. We observed
that 4D-optimized beam tracking provided a similar uniformity of film darkening to 3Doptimized beam tracking for the moving target, with mean optical densities of film in the
target region of 1.00 ± 0.14 and 1.00 ± 0.10, respectively. However, 4D-optimized beam
tracking provided much less dose to the avoidance region than 3D-optimized beam tracking,
as seen in the lighter film exposure in that region, with mean optical densities in the
avoidance region of 0.26 versus 0.71, respectively, and max optical densities in the
avoidance region of 0.79 versus 1.37, respectively. Thus, using 4D-optimized beam tracking
instead of 3D-optimized beam tracking reduced the mean film exposure in the avoidance
region by 63% and reduced the max film exposure in the avoidance region by 42%. These
measurements support our findings in-silico and provide evidence that our 4D-optimized
beam tracking approach is technically feasible to deliver using a carbon ion synchrotron in a
research laboratory.

4. Discussion
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In this work, we proposed a new 4D-optimized beam tracking approach for scanned ionbeam therapy and compared it against an existing 3D-optimized beam-tracking approach
using simulation studies in 4D phantoms and a simple experiment with moving films. The
major finding of this study is that 4D-optimized scanned ion beam tracking reduced the
maximum dose to avoidance volumes near a moving target compared with 3D-optimized
scanned ion beam tracking. In addition, 4D-optimized beam tracking substantially improved
target dose homogeneity for a thoracic CTV, compared with 3D-optimized beam tracking.
In our water phantom study, we demonstrated that a drastic reduction in dose to an
avoidance volume near a moving target is possible using 4D-optimized beam tracking
instead of 3D-optimized beam tracking. The clinical significance of this finding is unclear at
this time and will likely depend greatly on the exact motion characteristics of the target and
avoidance tissues for individual patients. In our lung cancer patient study, we observed more
modest sparing of an avoidance volume (the heart) using 4D optimization. The less dramatic
sparing of the avoidance volume seen in the patient compared with the water phantom is
likely a consequence of the similar motion between the target and the avoidance volume,
i.e., the heart.
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Thus, it appears that differential motion between target and avoidance volumes is a likely
prerequisite to achieve clinically significant reductions in dose to avoidance volumes using
4D-optimized scanned ion beam tracking. Therefore, more patient studies are required to
identify patient populations that would benefit most from this therapy. Of perhaps equal
importance, we found that 4D-optimized beam tracking could drastically improve target
dose coverage and dose uniformity for the lung cancer patient. This improved target
coverage compared with 3D-optimized beam tracking appears to persist even when
treatment planning and treatment delivery occur on different days, despite changes in
breathing and organ motion. This finding potentially benefits a large class of patients with
targets that undergo organ motion during treatment. Also, 3D-optimized beam tracking
seems to pose a risk for degraded uniformity of tumor dose, compared to both 4D-optimized
beam tracking and static dose simulations. This cautionary finding suggests that using beam
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tracking for deforming tissue without using 4D optimization or other correction methods
may provide dosimetrically worse coverage than, for example, perfect beam gating.
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For 3D-optimized beam tracking for the lung patient, this finding of non-uniform target dose
for “perfect” tracking agrees with previous studies of Bert and Rietzel (2007) and van de
Water et al. (2009), which reported that dose degradation can result from issues that are not
considered in 3D-optimized beam tracking, namely rotations, deformations, and changes in
scattering properties of tissue upstream to the target. For example, if the target rotates, the
entrance channel dose for individual pencil beams can overlap in irregular patterns. If the
target deforms, the geometric spacing between pencil beams may change, and due to the
high dose gradients for each pencil beam, one may observe overdose when volume
contraction occurs and underdose when volume dilation occurs. Further, if the target moves,
even rigidly, beneath heterogeneous tissue upstream of the target, for example, a lung tumor
moving beneath ribs, the multiple Coulomb scattering of individual pencil beams, and thus
distribution of off-axis target dose contributions, will not be uniform for all motion states
even if the range variations are compensated by beam tracking. Some of these issues were
recently solved by Lüchtenborg et al. (2011). The advantage of their method compared to
ours might be faster patient throughput, since their technique allows irradiation of the patient
during any given motion state. In contrast, our approach solves a 4D field that potentially
better spares avoidance volumes and might offer slightly more uniform target dose but must
be delivered during specific motion states and could require long treatment times, similar to
gating. However, a new 4D treatment control system developed by Graeff et al. (in press)
should allow temporal interleaving of the irradiation of 4D-optimized fields and greatly
reduce delivery time for 4D-optimized scanned ion beam tracking. Using such a system, we
speculate that, at worst, our approach could be as slow as beam gating. However, by using
temporal interleaving of the 4D-optimized irradiations, i.e., continuous switching and
updating of the list of completed and remaining pencil beams required for each motion state,
we could irradiate the patient quasi-continuously as the patient breathes freely and, thus, in
many cases our method might be substantially faster than a beam gating approach.
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In comparison to published literature on 4D-optimization for photon therapy, our approach
was similar to that of Trofimov et al. (2005), using a deforming dose calculation grid and
discrete motion states, though scanned ion beam therapy includes an additional degree of
freedom compared to photon therapy, due to the multiple isoenergy layers. Our findings for
the lung patient are consistent with their findings, which showed only slight reductions of
dose to avoidance volumes for lung and liver patients using 4D-optimized photon beam
tracking instead of photon beam gating. Similar to Chin and Otto (2011), we observed, in a
phantom study, 4D optimization has a large ability to spare an avoidance volume near a
moving target. In comparison with the approach of Graeff et al. (in press), our method was
similar in how we calculated the 4D dose contribution to each voxel from each ion pencil
beam for each motion state and included these in 4D optimization. However, our approach
differs from theirs in the starting conditions and the boundary conditions of optimization.
Namely, their method predetermined the motion state to irradiate given ion pencil beams
with motives to minimize treatment time and to eliminate the need for range-tracking
hardware. In contrast, our method allowed ion pencil beams to irradiate in any motion state
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that best met our objectives of uniform target dose coverage and minimal dose to avoidance
volumes. Thus, we expect that our method may generally require longer irradiation times
than theirs but achieve better sparing of designated avoidance volumes near a moving target.
Our study had several notable strengths. To our knowledge, this is the first study of 4D
optimization for scanned ion beam tracking therapy reported in the literature. We achieved
improved target dose coverage and reduced dose to avoidance volumes by incorporating the
entire 4DCT data set into 4D optimization of the scanned ion fields. Since we use the 4DCT
and deformable image registration vectors in optimization, our approach provided a more
uniform target dose than 3D-optimized beam tracking for a moving target in heterogeneous
tissue. A further strength of this study was that we validated our work experimentally using
a scanned carbon ion beam and a moving phantom.
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This study had several limitations. One was that while we did consider patient motion in
treatment planning, we did not consider uncertainties in patient motion during treatment plan
optimization, and we assumed that the exact characteristics of patient anatomy and motion
could be represented by a single planning 4DCT. Though our approach allowed variation in
respiratory rate, we ultimately assumed that motion was perfectly periodic. Any substantial
deviations from that assumption could result in treatment failure. However, this limitation
was not important in the context of this study because we only sought to demonstrate
feasibility that 4D optimization could potentially provide a benefit for scanned ion therapy
for moving organs. A second limitation was that we only considered absorbed dose from
scanned carbon ion therapy, that is, our modifications of the TRiP4D research code to allow
simulation of 4D-optimized beam tracking did not allow optimization of RBE-weighted
dose for our lung patient. Further work is needed to connect our approach with a method to
optimize RBE-weighted dose, such as the Local Effect Model used at GSI (Scholz et al.,
1997; Elsässer et al., 2010). However, the implementation of this in the TPS appears to be a
technically straightforward task. Third, in this work, we encountered computer memory
limitations during 4D optimization due to the large problem size when using our current 32bit treatment planning system. Therefore, we downsampled the 4DCT images from original
voxel sizes of (0.98 × 0.98 × 2.5) mm3 to voxel sizes of (2.93 × 2.93 × 2.5) mm3. This
limitation is currently being addressed by extension of TRiP4D to utilize 64-bit computer
architecture. A fourth limitation was that we only investigated one minimization algorithm,
i.e., the conjugate gradient method, which may converge on local minima rather than a
global minimum. The additional degrees of temporal freedom present in the objective
function for 4D-optimized tracking could potentially increase or decrease the presence of
local minima. Further studies are needed to investigate uniqueness of found minima and to
investigate convergence criteria for this method that best ensure the optimal 4D dose
distributions are found during minimization. Fifth, we only investigated one beam angle for
each test case. However, our codes can be used to optimize multiple beams simultaneously
to plan 4D-optimized intensity modulated particle therapy. Some of these limitations were
intended by the design of our study and allowed us to see things that could have otherwise
been confounded by increasing the complexity of our study. While we acknowledge these
limitations of our work, they did not prevent us from achieving our goals, which were to
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demonstrate proof-of-concept for a new beam tracking approach using 4D optimization and
to investigate possible dose reductions for avoidance volumes near moving targets.
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4D optimization for scanned ion therapy has many possible avenues for future work. The
incorporation of motion and setup uncertainties into treatment planning via robust 4D
optimization may provide a more reliable and stable treatment than that proposed here.
While several studies have demonstrated the ability of robust optimization to mitigate
uncertainties in treatment planning and patient alignment for particle therapy (Pflugfelder et
al., 2007; Lomax, 2008; Meyer et al., 2010; Liu et al., 2012), to our knowledge, no studies
have yet incorporated respiratory motion information into robust optimization routines for
particle therapy. Those 4D robust-optimization efforts will likely face high computational
challenges since the optimization matrix typically grows by the product of the number of
uncertainties simulated and the number of motion states modeled but may become feasible
with continued advances in high-performance computing. For patients with slightly irregular
motion trajectories, it should be theoretically possible to incorporate several 4DCT series
into the optimization of a single beam-tracking plan that is more robust to each possible
trajectory represented by the individual 4DCTs. For chaotic motion, such as seen in the
abdomen near the bowel, the 4D optimization concept could potentially be modified to
provide a robust 3D field solution that is optimized using multiple 3DCT image sets
acquired, for example, on different days prior to treatment.
In summary, we proposed a 4D-optimized beam tracking approach for scanned ion therapy
that provided reduced dose to avoidance volumes and improved target dose coverage for a
thoracic CTV, compared with 3D-optimized beam tracking. Theoretically, these dosimetric
advantages can be used either to provide reduced risk of treatment side effects when target
doses are designed for a standard tumor control probability or can allow increased target
doses and improved tumor control probability when risks of treatment side effects are
allowed to approach those risk levels typical of standard care. Either avenue may be
valuable to improving patient outcomes.
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Figure 1.

Schematic drawing comparing 4D- versus 3D-optimized scanned ion beam tracking in
beam's eye view. A circular target (black) moves between three motion states. For 3Doptimized tracking (a, b, and c) pencil beams (smaller blue circles) track the target motion
and deliver identical particle fluence for each motion state. For 4D-optimized tracking,
fluence is reduced for Motion State 2 (e) when the target is closest to the organ at risk
(green). To compensate, fluence must be increased for pencil beams in Motion States 1 and
3 when the target is furthest from the organ at risk (d and f). Relative fluence is indicated by
the shade of blue for each pencil beam.
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Figure 2.

Sagittal CT slice for the lung cancer patient in the reference motion state at end-exhale. The
CTV is indicated by the orange contour (right), and the heart contour is shown in white
(left). The overlaid red vectors indicate the YZ components of the deformable image
registration vectors and show the movement of tissue to a different motion state at fullinhale.
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Figure 3.
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Beam tracking system for scanned ion therapy implemented at GSI. The ion beam is
produced by linear and synchrotron acceleration and extracted by a radiofrequency (RF)
knockout exciter. Dipole scanner magnets steer the ion pencil beams laterally to achieve
target coverage and to track target motion. A system of acrylic wedges mounted on linear
drive motors modifies the range of individual pencil beams to track changes in radiological
depth of the target (Saito et al., 2009). A motion monitoring system provides feedback to the
4D therapy control system, which transmits precomputed beam tracking offsets for each
pencil beam and each motion state to the scanner magnets and wedge system, so that each
pencil beam follows the target motion. The ionization monitor chamber detects the number
of particles delivered for each pencil beam in a given motion state. Furthermore, the RF
knockout exciter is used to gate the beam as needed for each motion state.
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Figure 4.

Top view of our experimental setup for the 4D-optimized beam tracking experiment. Our
phantom consisted of 2 acrylic blocks that held radiographic films. The first phantom piece
was positioned stationary upstream of the target. The second moving target phantom piece
was mounted on a motion table designed for sinusoidal 1D motion with 2-cm amplitude,
driven by an electric DC motor. A laser distance sensor monitored the position of the motion
table and transmitted a signal to the 4D treatment control system, which determined the
motion state of the phantom for 4D treatment delivery.
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Beam's eye views of carbon ion scan patterns, i.e., fluence maps, for a single iso-energy
layer (201.65 MeV/u) comparing 3D optimized beam tracking (a,b,c) and 4D optimized
beam tracking (d,e,f). The ion scan path (thin pink line), stationary avoidance volume (blue
rectangle) and moving target (red circle) are shown for exemplary motion states 0 (a, d), 5
(b, e), and 10 (c, f). Relative particle numbers for each pencil beam are indicated by the size
of the black squares.
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Figure 6.

Objective function (top) and relative change in objective function (bottom) versus number of
iterations for 4D-optimized beam tracking for the water phantom. An initial increase of the
objective function was in early iterations, suggesting the presence of a local minimum,
followed by a gradual minimization continuing up to 105 iterations.
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Figure 7.

Target and avoidance volume dose statistics versus number of iterations for 4D-optimized
beam tracking for the water phantom. Target mean (D̄), standard deviation (error bars),
minimum (Dmin), and maximum dose (Dmax) are shown by the black markers connected by
solid lines. Avoidance volume mean and maximum dose are shown by the red markers
connected by dashed lines. During the first 10 iterations, dose is increased both to the target
and the avoidance volume. After the target dose stabilizes near iteration 1000, a continued
reduction in maximum dose to the avoidance volume is seen even up to 100,000 iterations.
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Figure 8.
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2D dose cuts for the moving sphere target in a water phantom with a static proximal
avoidance volume. 4D dose distributions were calculated for (a) 3D-optimized carbon static
plan for a non-moving target in the reference motion state, (b) 3D-optimized carbon beam
tracking plan for a moving target, and (c) 4D-optimized carbon beam tracking plan for a
moving target. Sphere target shown in the reference position (solid circle) and at maximal
displacement (dashed circle). The proximal avoidance structure (solid square) and water
above Z = 80 mm (dashed line) did not move. Illustrations of carbon pencil beam fluence for
each case are shown above the phantoms to demonstrate: (a) pencil beams do not move, (b)
pencil beams track the lateral motion of the sphere target, but fluence for each pencil beam
is identical to the static 3D plan, and (c) pencil beams track the lateral motion of the target
with pencil beam fluence optimized for each motion state to best spare the avoidance
structure and maintain target coverage.
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Figure 9.

Objective function (top) and relative change in objective function (bottom) versus number of
iterations for 4D-optimized beam tracking for the lung patient.
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Figure 10.

Sagittal cuts showing (a) CT image of lower thorax, (b) 3D dose for the 3D-optimized
carbon static plan ignoring motion, (c) 4D dose for the 3D-optimized beam tracking plan,
(d) 4D dose for the 4D-optimized carbon beam tracking plan. All 4D dose distributions were
transformed to the reference motion state at end-exhale for analysis. Note the increased
uniformity of CTV dose using 4D-optimized beam tracking (d) instead of 3D-optimized
beam tracking (c).
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Figure 11.

4D cumulative DVHs for the lung CTV and the heart shown in linear (top) and semilog
(bottom) scales comparing (1) 3D-optimized static plan (dashed red line), (2) 3D-optimized
beam tracking (dotted blue line), and (3) 4D-optimized beam tracking (solid black line). 4Doptimized beam tracking appears similar to the static plan with more uniform target dose
coverage and slightly reduced maximal dose to the heart, compared with 3D-optimized
beam tracking.
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Figure 12.
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Experimental film results for scanned carbon ion delivery of 4D-optimized beam tracking
(right) versus 3D-optimized beam tracking (left) using the GSI synchrotron facility. We
found that 4D-optimized beam tracking drastically reduced dose to the static avoidance
volume (red rectangle), as seen by less film darkening compared to 3D-optimized beam
tracking, while both approaches produced similar uniform darkening of the moving circular
target.
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